Biopharm has a network of 14 distribution centers, over 150 wholesalers, and over 3,000 pharmacies, delivering nearly 4,000 pharmaceutical products. It reported assets of $514 million and revenues of $265.4 million for the first six months of 2021. In 2021, it launched a new research laboratory and development in Réghaia, Algeria, valued at $1.3 million. The company employs over 2,500 people. Kerrar was appointed to his current position in 2020.